NATIONAL HEALTH INVESTORS INC — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that NATIONAL HEALTH INVESTORS INC filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $375.63M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $335.18M | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $319.84M | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $278.19M | Feb 25, 2025 |
| FY2023 | Dec 31, 2021 | $298.72M | Feb 20, 2024 |
| FY2021 | Sep 30, 2021 | $73.83M | Nov 8, 2021 |
| FY2021 | Jun 30, 2021 | $74.33M | Aug 9, 2021 |
| FY2021 | Mar 31, 2021 | $80.89M | May 10, 2021 |
| FY2020 | Dec 31, 2020 | $81.26M | Feb 22, 2021 |
| FY2021 | Sep 30, 2020 | $84.30M | Nov 8, 2021 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $80.06M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $54.42M | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $48.81M | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $35.80M | Feb 25, 2025 |
| FY2023 | Dec 31, 2021 | $0 | Feb 20, 2024 |
| FY2022 | Dec 31, 2020 | $0 | Feb 21, 2023 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $142.18M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $137.99M | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $135.65M | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $66.40M | Feb 25, 2025 |
| FY2023 | Dec 31, 2021 | $111.80M | Feb 20, 2024 |
| FY2021 | Sep 30, 2021 | $30.81M | Nov 8, 2021 |
| FY2021 | Jun 30, 2021 | $39.18M | Aug 9, 2021 |
| FY2021 | Mar 31, 2021 | $35.33M | May 10, 2021 |
| FY2020 | Dec 31, 2020 | $37.14M | Feb 22, 2021 |
| FY2021 | Sep 30, 2020 | $42.60M | Nov 8, 2021 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2015 | Dec 31, 2015 | $150.31M | Feb 18, 2016 |
| FY2015 | Dec 31, 2014 | $103.05M | Feb 18, 2016 |
| FY2015 | Dec 31, 2013 | $79.50M | Feb 18, 2016 |
| FY2014 | Dec 31, 2012 | $72.83M | Feb 17, 2015 |
| FY2013 | Dec 31, 2011 | $69.82M | Feb 18, 2014 |
| FY2012 | Dec 31, 2010 | $61.79M | Feb 25, 2013 |
| FY2011 | Dec 31, 2009 | $48.66M | Feb 15, 2012 |
| FY2010 | Dec 31, 2008 | $44.64M | Feb 17, 2011 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $236.56M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $207.77M | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $184.45M | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $185.34M | Feb 25, 2025 |
| FY2023 | Dec 31, 2021 | $210.86M | Feb 20, 2024 |
| FY2021 | Sep 30, 2021 | $157.50M | Nov 8, 2021 |
| FY2021 | Jun 30, 2021 | $108.51M | Aug 9, 2021 |
| FY2021 | Mar 31, 2021 | $56.91M | May 10, 2021 |
| FY2022 | Dec 31, 2020 | $232.15M | Feb 21, 2023 |
| FY2021 | Sep 30, 2020 | $176.53M | Nov 8, 2021 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $294.03M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $157.93M | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $49.56M | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $10.99M | Feb 25, 2025 |
| FY2023 | Dec 31, 2021 | $50.35M | Feb 20, 2024 |
| FY2022 | Dec 31, 2020 | $116.72M | Feb 21, 2023 |
| FY2021 | Dec 31, 2019 | $237.19M | Feb 22, 2022 |
| FY2020 | Dec 31, 2018 | $147.65M | Feb 22, 2021 |
| FY2019 | Dec 31, 2017 | $175.79M | Feb 19, 2020 |
| FY2018 | Dec 31, 2016 | $394.74M | Feb 19, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.80B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $2.61B | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | $2.49B | Feb 25, 2025 |
| FY2024 | Dec 31, 2022 | $2.51B | Feb 25, 2025 |
| FY2022 | Dec 31, 2021 | $2.84B | Feb 21, 2023 |
| FY2021 | Sep 30, 2021 | $2.91B | Nov 8, 2021 |
| FY2021 | Jun 30, 2021 | $3.08B | Aug 9, 2021 |
| FY2021 | Mar 31, 2021 | $3.18B | May 10, 2021 |
| FY2021 | Dec 31, 2020 | $3.12B | Feb 22, 2022 |
| FY2020 | Sep 30, 2020 | $3.14B | Nov 9, 2020 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.26B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $1.23B | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | $1.21B | Feb 25, 2025 |
| FY2023 | Dec 31, 2022 | $1.22B | Feb 20, 2024 |
| FY2022 | Dec 31, 2021 | $1.32B | Feb 21, 2023 |
| FY2021 | Sep 30, 2021 | $1.36B | Nov 8, 2021 |
| FY2021 | Jun 30, 2021 | $1.52B | Aug 9, 2021 |
| FY2021 | Mar 31, 2021 | $1.62B | May 10, 2021 |
| FY2021 | Dec 31, 2020 | $1.60B | Feb 22, 2022 |
| FY2020 | Sep 30, 2020 | $1.64B | Nov 9, 2020 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.52B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $1.37B | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | $1.25B | Feb 25, 2025 |
| FY2023 | Dec 31, 2022 | $1.27B | Feb 20, 2024 |
| FY2022 | Dec 31, 2021 | $1.51B | Feb 21, 2023 |
| FY2021 | Sep 30, 2021 | $1.54B | Nov 8, 2021 |
| FY2021 | Jun 30, 2021 | $1.55B | Aug 9, 2021 |
| FY2021 | Mar 31, 2021 | $1.55B | May 10, 2021 |
| FY2021 | Dec 31, 2020 | $1.51B | Feb 22, 2022 |
| FY2020 | Sep 30, 2020 | $1.49B | Nov 9, 2020 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.75B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $2.60B | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | $2.47B | Feb 25, 2025 |
| FY2023 | Dec 31, 2022 | $2.33B | Feb 20, 2024 |
| FY2016 | Dec 31, 2016 | $29.87M | Feb 17, 2017 |
| FY2016 | Dec 31, 2015 | $19.86M | Feb 17, 2017 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $19.62M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $24.29M | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $22.35M | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $19.29M | Feb 25, 2025 |
| FY2023 | Dec 31, 2021 | $37.41M | Feb 20, 2024 |
| FY2021 | Sep 30, 2021 | $48.39M | Nov 8, 2021 |
| FY2021 | Jun 30, 2021 | $32.54M | Aug 9, 2021 |
| FY2021 | Mar 31, 2021 | $113.38M | May 10, 2021 |
| FY2021 | Dec 31, 2020 | $43.34M | Feb 22, 2022 |
| FY2020 | Sep 30, 2020 | $42.20M | Nov 9, 2020 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2016 | Dec 31, 2016 | $1.13B | Feb 17, 2017 |
| FY2013 | Dec 31, 2013 | $80.08M | Feb 18, 2014 |
| FY2013 | Dec 31, 2012 | $0 | Feb 18, 2014 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 3 | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | 3 | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | 3 | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | 1 | Feb 25, 2025 |
| FY2023 | Dec 31, 2021 | 2 | Feb 20, 2024 |
| FY2021 | Sep 30, 2021 | 0 | Nov 8, 2021 |
| FY2021 | Jun 30, 2021 | 0 | Aug 9, 2021 |
| FY2021 | Mar 31, 2021 | 0 | May 10, 2021 |
| FY2020 | Dec 31, 2020 | 0 | Feb 22, 2021 |
| FY2021 | Sep 30, 2020 | 0 | Nov 8, 2021 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 3 | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | 3 | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | 3 | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | 1 | Feb 25, 2025 |
| FY2023 | Dec 31, 2021 | 2 | Feb 20, 2024 |
| FY2021 | Sep 30, 2021 | 0 | Nov 8, 2021 |
| FY2021 | Jun 30, 2021 | 0 | Aug 9, 2021 |
| FY2021 | Mar 31, 2021 | 0 | May 10, 2021 |
| FY2020 | Dec 31, 2020 | 0 | Feb 22, 2021 |
| FY2021 | Sep 30, 2020 | 0 | Nov 8, 2021 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 48.30M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | 45.69M | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | 43.41M | Feb 25, 2025 |
| FY2023 | Dec 31, 2022 | 43.39M | Feb 20, 2024 |
| FY2022 | Dec 31, 2021 | 45.85M | Feb 21, 2023 |
| FY2021 | Sep 30, 2021 | 45.85M | Nov 8, 2021 |
| FY2021 | Jun 30, 2021 | 45.85M | Aug 9, 2021 |
| FY2021 | Mar 31, 2021 | 45.85M | May 10, 2021 |
| FY2021 | Dec 31, 2020 | 45.19M | Feb 22, 2022 |
| FY2020 | Sep 30, 2020 | 44.73M | Nov 9, 2020 |